Building the future of cardiac health

Cardiac diseases are the world’s biggest killer, representing on third of all the deaths around the world. At Fluicell, we are creating groundbreaking tissue solutions for drug development and regenerative medicine with the power to change how we treat diseases. With our human tissue platform Nexocyte, we are building the future of cardiac health.

Learn more about heart disease and carodiotoxicity and discover the many ways in which Fluicell’s human tissue technology provides transformative solutions to cardiac safety screening, drug development and cardiac repair.

Read more about Fluicell’s pipeline for heart disease and cariotoxicity.

Share this article: